Sensitization of pancreatic cancer cells to radiation by cerium oxide nanoparticle-induced ROS production.

UNLABELLED Side effect of radiation therapy (RT) remains the most challenging issue for pancreatic cancer treatment. In this report we determined whether and how cerium oxide nanoparticles (CONPs) sensitize pancreatic cancer cells to RT. CONP pretreatment enhanced radiation-induced reactive oxygen species (ROS) production preferentially in acidic cell-free solutions as well as acidic human pancreatic cancer cells. In acidic environments, CONPs favor the scavenging of superoxide radical over the hydroxyl peroxide resulting in accumulation of the latter whereas in neutral pH CONPs scavenge both. CONP treatment prior to RT markedly potentiated the cancer cell apoptosis both in culture and in tumors and the inhibition of the pancreatic tumor growth without harming the normal tissues or host mice. Taken together, these results identify CONPs as a potentially novel RT-sensitizer as well as protectant for improving pancreatic cancer treatment. FROM THE CLINICAL EDITOR Pancreatic tumors remain some of the most notoriously treatment-unresponsive malignancies. Cerium oxide nanoparticles may be capable of sensitizing such cells to radiotherapy, as demonstrated in this study.

[1]  S. Seal,et al.  Protonated nanoparticle surface governing ligand tethering and cellular targeting. , 2009, ACS nano.

[2]  Robert N Grass,et al.  In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. , 2006, Environmental science & technology.

[3]  M. Das,et al.  Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. , 2007, Biomaterials.

[4]  S. Seal,et al.  Direct Synthesis of Nanoceria in Aqueous Polyhydroxyl Solutions , 2007 .

[5]  M. Abdelrahim,et al.  Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression , 2009, Molecular Cancer Therapeutics.

[6]  S. Seal,et al.  TEM/AFM investigation of size and surface properties of nanocrystalline ceria. , 2005, Journal of nanoscience and nanotechnology.

[7]  Michele Molinari,et al.  Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010. , 2011, World journal of gastroenterology.

[8]  Amit Kumar,et al.  Unveiling the mechanism of uptake and sub-cellular distribution of cerium oxide nanoparticles. , 2010, Molecular bioSystems.

[9]  Daxiang Cui,et al.  Folic acid-conjugated silica-modified gold nanorods for X-ray/CT imaging-guided dual-mode radiation and photo-thermal therapy. , 2011, Biomaterials.

[10]  R. Tarnuzzer,et al.  Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage. , 2005, Nano letters.

[11]  S. Seal,et al.  Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides , 2006, Nature nanotechnology.

[12]  P. Kupelian,et al.  Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[13]  L. Schwartz,et al.  Potential role of histone deacetylase inhibitors in mesothelioma: clinical experience with suberoylanilide hydroxamic acid. , 2006, Clinical lung cancer.

[14]  C. Bucana,et al.  Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas. , 2002, The American journal of pathology.

[15]  I. Fidler,et al.  In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice. , 1999, Neoplasia.

[16]  Sudipta Seal,et al.  The role of cerium redox state in the SOD mimetic activity of nanoceria. , 2008, Biomaterials.

[17]  I. Fidler,et al.  Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer. , 2002, Cancer research.

[18]  L. Vlahos,et al.  Amifostine: the first selective-target and broad-spectrum radioprotector. , 2007, The oncologist.

[19]  Sudipta Seal,et al.  Protection from radiation-induced pneumonitis using cerium oxide nanoparticles. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[20]  Sudipta Seal,et al.  Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. , 2007, Biomaterials.

[21]  W. Młynarski,et al.  Cytoprotective effect of amifostine in the treatment of childhood neoplastic diseases--a clinical study including the pharmacoeconomic analysis. , 2006, Pharmacological reports : PR.

[22]  J. Haveman,et al.  Clonogenic assay of cells in vitro , 2006, Nature Protocols.

[23]  Dan Yang,et al.  Direct Evidence for Hydroxyl Radical Scavenging Activity of Cerium Oxide Nanoparticles , 2011 .

[24]  Xiao-Dong Zhou,et al.  Toxicity of Cerium Oxide Nanoparticles in Human Lung Cancer Cells , 2006, International journal of toxicology.

[25]  Soumen Das,et al.  Combined cytotoxic and anti-invasive properties of redox-active nanoparticles in tumor-stroma interactions. , 2011, Biomaterials.

[26]  Jinhee Choi,et al.  Oxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cells. , 2008, Toxicology.

[27]  Jing Lin,et al.  Protein-directed one-pot synthesis of Ag microspheres with good biocompatibility and enhancement of radiation effects on gastric cancer cells. , 2011, Nanoscale.

[28]  S. Seal,et al.  Nanoceria exhibit redox state-dependent catalase mimetic activity. , 2010, Chemical communications.

[29]  Amit Kumar,et al.  A facile synthesis of PLGA encapsulated cerium oxide nanoparticles: release kinetics and biological activity. , 2012, Nanoscale.

[30]  Charalambos Kaittanis,et al.  Oxidase-like activity of polymer-coated cerium oxide nanoparticles. , 2009, Angewandte Chemie.

[31]  S. Seal,et al.  Size dependency variation in lattice parameter and valency states in nanocrystalline cerium oxide , 2005 .